1. Home
  2. SCZM vs BHVN Comparison

SCZM vs BHVN Comparison

Compare SCZM & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SCZM

Santacruz Silver Mining Ltd. Common Shares

N/A

Current Price

$7.64

Market Cap

1.2B

Sector

N/A

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$8.39

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCZM
BHVN
Founded
N/A
2013
Country
Canada
United States
Employees
N/A
274
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
SCZM
BHVN
Price
$7.64
$8.39
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
$28.85
AVG Volume (30 Days)
540.9K
1.9M
Earning Date
05-29-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.08
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$22.30
N/A
Revenue Next Year
$69.17
N/A
P/E Ratio
$14.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.90
$7.48
52 Week High
$17.65
$26.48

Technical Indicators

Market Signals
Indicator
SCZM
BHVN
Relative Strength Index (RSI) 34.66 31.82
Support Level $6.90 $8.40
Resistance Level $12.74 $11.92
Average True Range (ATR) 0.67 0.59
MACD -0.05 -0.07
Stochastic Oscillator 17.80 5.51

Price Performance

Historical Comparison
SCZM
BHVN

About SCZM Santacruz Silver Mining Ltd. Common Shares

Santacruz Silver Mining Ltd is engaged in the operation, acquisition, exploration, and development of mineral properties in Latin America, with a primary focus on silver and zinc, including lead and copper. The company earns the majority of its revenue from Zinc and Silver. The company's reportable operating segments are the Bolivar mine and processing plant, the Porco mine and processing plant, the Caballo Blanco Group, San Lucas, Zimapan, and Corporate and Other activities. Key revenue is generated from Zimapan.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: